Out of the 17 million Americans who have received the J&J vaccine, nine have died from blood clots afterward.
CDC recommends Pfizer, Moderna COVID-19 vaccines instead of Johnson & Johnson
The Facts Inside Our Reporter’s Notebook
Links
The Centers for Disease Control and Prevention (CDC) quickly approved an advisory panel recommendation Thursday that adults receive the Pfizer or Moderna COVID-19 vaccines over the Johnson & Johnson vaccine.
Although 17 million people in the United States have already taken the J&J shot, nine people have died after developing a rare blood clotting disorder called thrombosis with thrombocytopenia, the CDC's Advisory Committee on Immunization Practices said, according to USA Today.
Most people affected by blood clots were 30-to-49-year-old women.
CDC Director Dr. Rochelle Walensky supported the panel's decision several hours later.
“Today’s updated recommendation emphasizes CDC’s commitment to provide real-time scientific information to the American public,” Walensky said, according to The Washington Post.
The single-dose J&J vaccine was seen as a welcome alternative that could be used for people unlikely to come back for a second shot compared to the two-dose Pfizer and Moderna vaccines.
Last week, a non-peer-reviewed study showed that people who have had the J&J vaccine were at a greater risk of developing Guillain-Barré syndrome, a rare but severe autoimmune disorder.